Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.190
Neutral
RSI(14)
35.240
Neutral
STOCH(KDJ)(9,3,3)
31.148
Buy
ATR(14)
0.630
High Vlolatility
CCI(14)
-62.544
Neutral
Williams %R
78.909
Sell
TRIX(12,20)
-0.876
Sell
StochRSI(14)
100.000
Buy
Search
Oculis Holding AG
OCSAdd to Watchlist
11.310USD
+0.100+0.89%
Close 07-31 16:00（ET）Quotes delayed by 15 min
701.69MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.89%
5 Days
+1.62%
1 Month
-19.90%
6 Months
-61.04%
Year to Date
-43.37%
1 Year
-36.10%
Key Figures
11.340Open
11.350High
204.88KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.37%Turnover Ratio
11.210Prev. Close
10.870Low
1.52MTurnover
LossP/E Static
3.89P/B
0.00%Div Yield TTM
-42.21%ROA
34.47552wk High
0.61Volume Ratio
-85.78MNet Profit
55.87MShares
-2.1221EPS TTM
0.21Beta
-52.66%ROE
16.00052wk Low
4.28%Amplitude
--Gross Margin
701.69MMarket Cap
-5.82Reward/Risk
3.22%Risk Rate
Oculis Holding AG News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
11
analysts
Strong Buy
Current Rating
38.333
Target Price
+238.93%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Oculis Holding AG
OCS
11
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
27
argenx SE
ARGX
26
Kymera Therapeutics Inc
KYMR
24
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
11.087
Buy
MA10
11.312
Sell
MA20
12.276
Sell
MA50
14.448
Sell
MA100
20.932
Sell
MA200
22.011
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Oculis Holding AG Info
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.
Ticker SymbolOCS
CompanyOculis Holding AG
CEOSherif (Riad)
Websitehttps://oculis.com/
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52996.700
+618.700 (+1.18%)
28370.400
+209.500 (+0.74%)
7534.900
+59.800 (+0.80%)
14607.000
-142.000 (-0.96%)
62873.000
+21.000 (+0.03%)
6422.300
+56.900 (+0.89%)
78.702
-7.232 (-8.42%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4047.530
+6.100 (+0.15%)
FAQs
What is the current price of Oculis Holding AG (OCS)?
The current price of Oculis Holding AG (OCS) is 11.31.
What is the symbol of Oculis Holding AG?
The ticker symbol of Oculis Holding AG is OCS.
What is the 52-week high of Oculis Holding AG?
The 52-week high of Oculis Holding AG is 34.48.
What is the 52-week low of Oculis Holding AG?
The 52-week low of Oculis Holding AG is 16.00.
What is the market capitalization of Oculis Holding AG?
The market capitalization of Oculis Holding AG is 701.69M.
Is Oculis Holding AG (OCS) currently rated as Buy, Hold, or Sell?
According to analysts, Oculis Holding AG (OCS) has an overall rating of STRONG BUY, with a price target of 38.33.
What is the Earnings Per Share (EPS TTM) of Oculis Holding AG (OCS)?
The Earnings Per Share (EPS TTM) of Oculis Holding AG (OCS) is -2.39.